Edition:
United Kingdom

Profile: Beijing Tiantan Biological Products Corp Ltd (600161.SS)

600161.SS on Shanghai Stock Exchange

17.28CNY
17 Aug 2018
Change (% chg)

¥-0.29 (-1.65%)
Prev Close
¥17.57
Open
¥17.66
Day's High
¥17.78
Day's Low
¥17.15
Volume
1,697,364
Avg. Vol
5,786,550
52-wk High
¥29.08
52-wk Low
¥16.93

BEIJING TIANTAN BIOLOGICAL PRODUCTS CORPORATION LIMITED is a China-based company principally engaged in the biopharmaceutical businesses. The Company’s primary products include preventive products, blood products and other biological products, such as the influenza A (H1N1) vaccines (split, inactivated),hepatitis B vaccines, poliomyelitis vaccines, measles-mump-rubella (MMR) vaccines, encephalitis B vaccines, influenza vaccinations, bacterial vaccines, human serum albumin (HSA) and intravenous immunoglobulin (IVIG), among others. The Company mainly distributes its products within domestic markets and to Hong Kong markets.

Company Address

Beijing Tiantan Biological Products Corp Ltd

No. 4
Sanjianfang Nanli, Chaoyang Dist
BEIJING   BEJ   100024
P: +8610.65434018
F: +8610.65436770

Company Web Links